Marcello Tucci

3.4k total citations
100 papers, 1.9k citations indexed

About

Marcello Tucci is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marcello Tucci has authored 100 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 46 papers in Oncology and 44 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marcello Tucci's work include Prostate Cancer Treatment and Research (65 papers), Radiopharmaceutical Chemistry and Applications (42 papers) and Bone health and treatments (15 papers). Marcello Tucci is often cited by papers focused on Prostate Cancer Treatment and Research (65 papers), Radiopharmaceutical Chemistry and Applications (42 papers) and Bone health and treatments (15 papers). Marcello Tucci collaborates with scholars based in Italy, Switzerland and United States. Marcello Tucci's co-authors include Giorgio V. Scagliotti, Consuelo Buttigliero, Massimo Di Maïo, Francesca Vignani, Valentina Bertaglia, Luigi Dogliotti, Alberto Angeli, Alfredo Berruti, Giulia Courthod and Paolo Bironzo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Marcello Tucci

97 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcello Tucci Italy	24	1.3k	748	593	403	369	100	1.9k
Consuelo Buttigliero Italy	23	1.0k 0.8×	692 0.9×	247 0.4×	411 1.0×	397 1.1×	91	1.7k
Philip J. Saylor United States	25	1.2k 0.9×	1.0k 1.4×	326 0.5×	492 1.2×	393 1.1×	82	2.5k
Diletta Bianchini United Kingdom	22	1.6k 1.2×	659 0.9×	755 1.3×	356 0.9×	768 2.1×	68	2.1k
Daniel Keizman Israel	23	1.0k 0.8×	678 0.9×	315 0.5×	320 0.8×	332 0.9×	98	1.7k
Géralyn C. Trudel United States	11	1.1k 0.8×	434 0.6×	400 0.7×	365 0.9×	417 1.1×	24	1.5k
Edoardo Francini Italy	20	632 0.5×	554 0.7×	215 0.4×	210 0.5×	291 0.8×	73	1.2k
Miguel Gil‐Gil Spain	23	619 0.5×	814 1.1×	216 0.4×	322 0.8×	396 1.1×	101	1.7k
Guilhem Roubaud France	19	1.1k 0.8×	702 0.9×	238 0.4×	439 1.1×	314 0.9×	132	1.6k
G. Gorzegno Italy	21	440 0.3×	836 1.1×	251 0.4×	249 0.6×	249 0.7×	51	1.4k
Edgar Ben‐Josef United States	19	973 0.7×	408 0.5×	339 0.6×	324 0.8×	176 0.5×	34	1.6k

Countries citing papers authored by Marcello Tucci

Since Specialization

Citations

This map shows the geographic impact of Marcello Tucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello Tucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello Tucci more than expected).

Fields of papers citing papers by Marcello Tucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello Tucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello Tucci. The network helps show where Marcello Tucci may publish in the future.

Co-authorship network of co-authors of Marcello Tucci

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello Tucci. A scholar is included among the top collaborators of Marcello Tucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello Tucci. Marcello Tucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fiorica, Francesco, Matteo Bauckneht, Jacopo Giuliani, et al.. (2025). Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints. Cancers. 17(13). 2247–2247.

Turco, Fabio, Giorgio Treglia, Silke Gillessen, et al.. (2024). Maximal androgen blockade therapy (MAB) for prostate cancer (PC) and risk of bone fractures: A systematic literature review and meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). e17111–e17111. 1 indexed citations

Turco, Fabio, et al.. (2024). Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis. Cells. 13(16). 1396–1396. 2 indexed citations

Turco, Fabio, Rosario Francesco Di Stefano, Orazio Caffo, et al.. (2024). Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology. Clinical Genitourinary Cancer. 23(1). 102255–102255. 1 indexed citations

Tucci, Marcello, Laura Cosmai, Marta Pirovano, et al.. (2024). How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists. Cancer Treatment Reviews. 125. 102692–102692. 2 indexed citations

Turco, Fabio, Silke Gillessen, Giorgio Treglia, et al.. (2023). Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 27(3). 385–392. 4 indexed citations

Tucci, Marcello, et al.. (2022). Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. Cells. 11(5). 803–803. 34 indexed citations

Stefano, Rosario Francesco Di, Marcello Tucci, Fabio Turco, et al.. (2021). Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. Prostate Cancer and Prostatic Diseases. 24(3). 812–825. 3 indexed citations

Leone, Gianmarco, Consuelo Buttigliero, Rosario Francesco Di Stefano, et al.. (2020). Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. Critical Reviews in Oncology/Hematology. 152. 102994–102994. 11 indexed citations

10.

Iacovelli, Roberto, Chiara Ciccarese, Orazio Caffo, et al.. (2020). The prognostic value of pain in castration-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases. 23(4). 654–660. 10 indexed citations

11.

Buttigliero, Consuelo, Marcello Tucci, Cristina Sonetto, et al.. (2020). Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. Minerva Urologica e Nefrologica. 72(6). 737–745. 4 indexed citations

12.

Tucci, Marcello, Orazio Caffo, Consuelo Buttigliero, et al.. (2019). Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. Cancer Treatment Reviews. 74. 35–42. 22 indexed citations

13.

Raimondi, Alessandra, Raffaele Ratta, Elena Verzoni, et al.. (2019). Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population. Clinical Genitourinary Cancer. 17(4). 291–298. 24 indexed citations

14.

Stefano, Rosario Francesco Di, Consuelo Buttigliero, Emmanuele De Luca, et al.. (2018). Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review. Clinical Genitourinary Cancer. 16(6). e1087–e1090. 4 indexed citations

15.

Nunno, Vincenzo Di, Emmanuele De Luca, Consuelo Buttigliero, et al.. (2018). Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 129. 124–132. 13 indexed citations

16.

Buttigliero, Consuelo, Marcello Tucci, Francesca Vignani, Giorgio V. Scagliotti, & Massimo Di Maïo. (2017). Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. Cancer Treatment Reviews. 54. 1–9. 45 indexed citations

17.

Caffo, Orazio, Elisa Biasco, Gaetano Facchini, et al.. (2016). Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study. Annals of Oncology. 27. vi252–vi252. 2 indexed citations

18.

Courthod, Giulia, Marcello Tucci, Massimo Di Maïo, & Giorgio V. Scagliotti. (2015). Papillary renal cell carcinoma: A review of the current therapeutic landscape. Critical Reviews in Oncology/Hematology. 96(1). 100–112. 98 indexed citations

19.

Iuliani, Michele, Francesco Pantano, Consuelo Buttigliero, et al.. (2015). Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. SHILAP Revista de lepidopterología. 11(4). 81–88.

20.

Berruti, Alfredo, Luigi Dogliotti, G. Gorzegno, et al.. (1999). Differential Patterns of Bone Turnover in Relation to Bone Pain and Disease Extent in Bone in Cancer Patients with Skeletal Metastases. Clinical Chemistry. 45(8). 1240–1247. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact